Literature DB >> 8255794

Clinical significance of late potential in patients with Duchenne muscular dystrophy.

M Kubo1, S Matsuoka, Y Taguchi, H Akita, Y Kuroda.   

Abstract

The relationship between late ventricular potentials (LP) and myocardial ischemic changes or ventricular arrhythmias was investigated in patients with Duchenne muscular dystrophy (DMD). Twenty-six DMD patients aged 10-33 years (mean 18.2 years) and 27 age-matched healthy volunteers were studied. Ventricular arrhythmias were detected by 24-h Holter ECGs and LPs were determined using signal-averaged ECGs. In DMD patients filtered QRS duration, late duration, and low-amplitude signal under 40 microV were significantly prolonged compared with those of the controls. The root mean square voltage of the f-QRS complex in the last 40 ms was lower in DMD patients than in the controls. None of the control subjects had LP. However, LP was detected in 8 (31%) of the 26 DMD patients. The patients with LP had more frequent ST-T depression and ventricular arrhythmias than the patients without LP. LP had 60% sensitivity and 87% specificity for documented ventricular arrhythmias. It is concluded that LP in DMD patients indicates the presence of substrate for ventricular arrhythmias associated with local myocardial fibrosis, and is useful in identifying those at high risk for malignant ventricular arrhythmias.

Entities:  

Mesh:

Year:  1993        PMID: 8255794     DOI: 10.1007/BF00795373

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  19 in total

1.  Late ventricular potentials and spontaneous and induced ventricular arrhythmias in dilated or hypertrophic cardiomyopathies. A prospective study about 83 patients.

Authors:  J P Fauchier; P Cosnay; B Moquet; H Balleh; P Rouesnel
Journal:  Pacing Clin Electrophysiol       Date:  1988-11       Impact factor: 1.976

2.  The pathology of the heart in progressive muscular dystrophy: epimyocardial fibrosis.

Authors:  K A Frankel; R J Rosser
Journal:  Hum Pathol       Date:  1976-07       Impact factor: 3.466

3.  Cardiac rhythm and conduction in Duchenne's muscular dystrophy: a prospective study of 20 patients.

Authors:  J K Perloff
Journal:  J Am Coll Cardiol       Date:  1984-05       Impact factor: 24.094

4.  Cardiac conduction abnormalities in children with Duchenne's progressive muscular dystrophy: electrocardiographic features and morphologic correlates.

Authors:  S K Sanyal; W W Johnson
Journal:  Circulation       Date:  1982-10       Impact factor: 29.690

5.  Electrophysiologic and anatomic basis for fractionated electrograms recorded from healed myocardial infarcts.

Authors:  P I Gardner; P C Ursell; J J Fenoglio; A L Wit
Journal:  Circulation       Date:  1985-09       Impact factor: 29.690

6.  Significance of signal-averaged electrocardiography in relation to endomyocardial biopsy and ventricular stimulation studies in patients with ventricular tachycardia without clinically apparent heart disease.

Authors:  D Mehta; W J McKenna; D E Ward; M J Davies; A J Camm
Journal:  J Am Coll Cardiol       Date:  1989-08       Impact factor: 24.094

7.  Prevalence of late potentials in patients with and without ventricular tachycardia: correlation with angiographic findings.

Authors:  G Breithardt; M Borggrefe; U Karbenn; R R Abendroth; H L Yeh; L Seipel
Journal:  Am J Cardiol       Date:  1982-06       Impact factor: 2.778

8.  Histopathological study of the conduction system of the heart in Duchenne progressive muscular dystrophy.

Authors:  H Nomura; K Hizawa
Journal:  Acta Pathol Jpn       Date:  1982-11

9.  Cardiomyopathy of Duchenne muscular dystrophy.

Authors:  L D'Orsogna; J P O'Shea; G Miller
Journal:  Pediatr Cardiol       Date:  1988       Impact factor: 1.655

10.  Continuous local electrical activity. A mechanism of recurrent ventricular tachycardia.

Authors:  M E Josephson; L N Horowitz; A Farshidi
Journal:  Circulation       Date:  1978-04       Impact factor: 29.690

View more
  2 in total

Review 1.  Cardiopulmonary support in duchenne muscular dystrophy.

Authors:  Josef Finsterer
Journal:  Lung       Date:  2006 Jul-Aug       Impact factor: 2.584

2.  Arginine metabolism by macrophages promotes cardiac and muscle fibrosis in mdx muscular dystrophy.

Authors:  Michelle Wehling-Henricks; Maria C Jordan; Tomomi Gotoh; Wayne W Grody; Kenneth P Roos; James G Tidball
Journal:  PLoS One       Date:  2010-05-21       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.